TrialBlood advances2025

Ibrutinib plus rituximab vs ibrutinib monotherapy in patients with Waldenström macroglobulinemia: a pooled analysis.

Alberto Guijosa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.